Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor
about
Activation of signalling by the activin receptor complexInhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanismActivin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiationCloning and characterization of a human type II receptor for bone morphogenetic proteinsBMP type I receptor inhibition reduces heterotopic [corrected] ossificationType I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activinSpecific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2Activin B can signal through both ALK4 and ALK7 in gonadotrope cellsSmad8 mediates the signaling of the ALK-2 [corrected] receptor serine kinaseIdentification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta familyFocal adhesion kinase (FAK) expression and activation during lens developmentDifferential effects of follistatin on nonhuman primate oocyte maturation and pre-implantation embryo development in vitro.Bone morphogenetic protein receptors and activin receptors are highly expressed in ossified ligament tissues of patients with ossification of the posterior longitudinal ligament.The types II and III transforming growth factor-beta receptors form homo-oligomers.Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects.Characterization and cloning of a receptor for BMP-2 and BMP-4 from NIH 3T3 cells.GH3 pituitary tumor cells contain heteromeric type I and type II receptor complexes for transforming growth factor beta and activin-A.Cripto/GRP78 modulation of the TGF-β pathway in development and oncogenesisAntagonism of activin by activin chimeras.The role of bone morphogenetic proteins in ankylosing spondylitis.An activin mutant with disrupted ALK4 binding blocks signaling via type II receptors.Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.Smad7 is an activin-inducible inhibitor of activin-induced growth arrest and apoptosis in mouse B cells.Signaling pathways in skeletal formation: a role for BMP receptors.Identification of receptors and Smad proteins involved in activin signalling in a human epidermal keratinocyte cell line.Actions of activins, inhibins and follistatins: implications in anterior pituitary function.Molecular cloning of tyrosine kinases in the early Xenopus embryo: identification of Eck-related genes expressed in cranial neural crest cells of the second (hyoid) arch.zALK-8, a novel type I serine/threonine kinase receptor, is expressed throughout early zebrafish development.Ascending the PEAK1 toward targeting TGFβ during cancer progression: Recent advances and future perspectives.
P2860
Q24308084-A8E3A10B-748E-43A2-AB59-381E3909E812Q24317361-68151FA8-79A4-474D-84C0-746EBB3F2B94Q24319935-A6C442CA-462A-49F1-9C59-11F81251BD3BQ24561622-47769D4E-D9C2-43B7-B363-DA6510AC2C51Q24611307-1D8A312F-0CF7-4C66-8A48-3A7D2216A1D1Q24612297-406CB9BD-49EF-4E44-9A65-31162DEEE28FQ28283345-4E8A80CD-A968-430F-8DE1-4E611717E90CQ28575475-7FDED793-7A29-4D8A-86DA-458F27D44BB3Q28584256-7D03F04B-D1C2-40AC-87C8-EB8A1530B490Q28591844-B1453C52-5BAB-4223-A11F-29DA820DD024Q28645969-AD7ED41F-D24E-4E41-9F0C-FE9CC56F21A9Q33573789-FE4675B2-7809-4445-8597-8CD2F0B1527AQ35764296-223EA4D2-74DB-4446-90DA-30F0DF0AD921Q36234419-BB8B0E80-5011-4E36-92BD-4913C4E3F5CFQ36235769-3D839C07-966F-4F26-A5FA-594D8F9EF880Q36665327-55DA1D88-AA7C-49B6-B392-EC587253E73FQ36712439-F37A3757-972D-4207-9CDC-327D993CEC88Q37045189-D6F548B7-577F-4455-A71D-FEBEBE45E17DQ37847427-B1CCF6CC-3A2F-496B-AAEE-84988899C1E8Q38031830-A86849E4-280B-47C3-B9C0-34EFFE7F35FEQ40559814-6CFCF66B-C224-495C-BDFC-7F7D80A5BDAFQ40810320-01E9B89C-875D-44DA-8A9F-3B760FC612E5Q41009902-2D10A8BB-07AB-4E1A-87AD-0B4812683A5AQ41029855-24B106B2-5F5B-4B3D-9C52-B628EE7FEDCDQ41038879-63800EED-3BB3-41B2-9CED-F2AD08B4F6EAQ46193824-607D1403-D6FE-469A-846A-FF595FC9BB91Q46217235-5C4CDC2B-23C3-4F7F-B416-9BAD81CBFEAFQ47073607-309B05E2-1569-4EF2-A552-48AD13CD78DFQ49385083-DFF272AD-1327-4A9B-9D5E-34A924E9F633
P2860
Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor
description
1993 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 1993
@ast
im Dezember 1993 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1993/12/01)
@sk
vědecký článek publikovaný v roce 1993
@cs
wetenschappelijk artikel (gepubliceerd op 1993/12/01)
@nl
наукова стаття, опублікована в грудні 1993
@uk
name
Cloning and characterization o ...... as an activin type I receptor
@ast
Cloning and characterization o ...... as an activin type I receptor
@en
Cloning and characterization o ...... as an activin type I receptor
@nl
type
label
Cloning and characterization o ...... as an activin type I receptor
@ast
Cloning and characterization o ...... as an activin type I receptor
@en
Cloning and characterization o ...... as an activin type I receptor
@nl
prefLabel
Cloning and characterization o ...... as an activin type I receptor
@ast
Cloning and characterization o ...... as an activin type I receptor
@en
Cloning and characterization o ...... as an activin type I receptor
@nl
P2860
P356
P1476
Cloning and characterization o ...... as an activin type I receptor
@en
P2093
P2860
P304
11242-11246
P356
10.1073/PNAS.90.23.11242
P407
P577
1993-12-01T00:00:00Z